Search results

Found 245 pages
AUTHOR: Katrina Megget

Results per page

10 20 50 100

Sort by

Relevance Date

19 Nov 2010:

4,500 Bayer jobs to be axed

The raft of pharma job cuts continues this week, with Bayer next to announce some 4,500 positions are to go.  - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/4,500_bayer_jobs_to_be_axed_982036

15 Oct 2008:

Wyeth pulls Europe application for Ellefore/Pristiq

Wyeth Pharmaceuticals has pulled its European Marketing Authorisation for its drug Ellefore/Pristiq (desvenlafaxine) as a treatment of major depressive disorder. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/wyeth_pulls_europe_application_for_elleforepristiq_986594

23 Dec 2010:

BMS/Pfizer blood thinner tops Sanofi rival

Bristol-Myers Squibb and Pfizer have published results that show their experimental blood thinner apixaban is “statistically superior” torival drug Lovenox (enoxaparin) by Sanofi-Aventis. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/bmspfizer_blood_thinner_tops_sanofi_rival_981264

20 Aug 2010:

Cymbalta gets support for broader use

The pressure of Eli Lilly’s looming patent cliff has beenreduced after a US Committee has recommended expanding the pain indication forits top selling drug Cymbalta (duloxetine HCL). - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/cymbalta_gets_support_for_broader_use_982566

17 Dec 2010:

GSK and Impax shake hands on Parkinson’s deal

GlaxoSmithKline has joined forces with Impax Pharmaceuticals to develop and commercialise the latter’s Parkinson’s Disease drug, which is currently in Phase III.  - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/gsk_and_impax_shake_hands_on_parkinsons_deal_981299

13 Oct 2008:

Roche hits another brick wall in Mircera saga

Roche’s anaemia drug Mircera has been barred from the USA after a US appeals court upheld a previous ruling alleging the Swiss company’s drug infringes Amgen patents. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/roche_hits_another_brick_wall_in_mircera_saga_986622

7 Oct 2010:

Quintiles adds to its 'Prime' clinical sites

Quintiles has struck up a strategic alliance with the SeoulNational University Hospital in celebration of its tenth year anniversary inSouth Korea. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/quintiles_adds_to_its_prime_clinical_sites_982293

11 Dec 2008:

Biotech asks US Government for help

The Biotechnology Industry Organisation is asking the US Government for a financial stimulus for small biotech companies that are struggling during the credit crunch. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/biotech_asks_us_government_for_help_986188

28 Jun 2011:

Icagen shares jump amid Pfizer takeover speculation

Shares for Icagen jumped more than 120% yesterday after news the biotech firm was contemplating a deal with drug giant Pfizer. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/icagen_shares_jump_amid_pfizer_takeover_speculation_980805

7 Oct 2008:

Avastin/Tarceva combo does not improve survival

Genentech and OSI Pharmaceuticals have announced the combination treatment of Avastin (bevacizumab) with Tarceva (erlotinib) has not shown to improve survival in a Phase III study. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/avastintarceva_combo_does_not_improve_survival_986661